Skip to main content
. 2020 Jul 28;74:46–52. doi: 10.1016/j.ijscr.2020.07.069

Table 1.

Clinicopathological features of the four cases with cHCC-CCA.

Case 1 2 3 4
Age 65 62 67 45
Sex M M F M
Background liver disease HCV-LC HBV-LC NASH Alcoholic LC
Child-Pugh C(11) C(11) B(8) C(10)
CEA [ng/mL] 2.4 3.1 5 11
CA19-9 [U/mL] 40 33.1 34.8 <0.6
AFP [ng/mL] 85.8 6.7 2075 642.3
DCP [mAU/mL] 84 59 380 18
Milan criteria Within Within (Beyond→) Within* Beyond
Kyoto criteria Within Within Within (Within→) Beyond**
Tumor number (total) 3 2 3 >10
Tumor number (cHCC-CCA) 1 1 1 1
Tumor size(cHCC-CCA) [cm] 1.4 1.1 2.1 3.6
Tumor size(maximum) [cm] 2.9 1.1 3 3.6
Recurrence Multiple liver cancer
Recurrence[month] 9
Outcome Alive Alive Alive Death
Survival time[month] 65 66 11 15
Cause of death Liver cancer

*Case 3 did not meet the Milan criteria preoperatively. However, she met the criteria on the postoperative examination. ** Case 4 met Kyoto criteria preoperatively, but did not meet Kyoto criteria on the postoperative examination. M: male, F: female, HCV: hepatitis C virus, HBV: hepatitis B virus, NASH: non-alcoholic steatohepatitis, LC: liver cirrhosis.